{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:56:10Z","timestamp":1785405370434,"version":"3.56.0"},"reference-count":26,"publisher":"AOSIS","issue":"1","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Background:\u00a0The hepatitis C virus (HCV) testing algorithm used in South African laboratories involves two tests; a serology test to detect anti-HCV antibodies and a confirmatory test to detect the presence of HCV ribonucleic acid (RNA). These tests usually require consecutive blood samples taken at more than one hospital visit, leaving patients with inconclusive diagnosis for weeks.\nObjectives:\u00a0This study aimed to describe the prevalence and proportion of HCV seropositive cases where diagnostic opportunities were missed among patients who attended public healthcare facilities in Johannesburg, South Africa.\nMethod:\u00a0This descriptive study was conducted as a retrospective analysis of laboratory data from the Department of Medical Virology, National Health Laboratory Service, Johannesburg, South Africa. Patients for whom HCV diagnosis were requested from 2017 to 2021 were included in the study.\nResults:\u00a0Over the five-year period, a total of 212 670 patients were tested for HCV antibodies and 8575 (4.04%) tested positive. The HCV seropositivity was recorded for 74.8% (6421\/8575) of males compared to females (23.6%; 2030\/8575;\u00a0p\u00a0&lt; 0.001). Only 25% (2183\/8575) of HCV seropositive patients had a linked HCV RNA quantitative PCR test result.\nConclusion:\u00a0Despite an overall HCV seroprevalence of 4% in this study, only one quarter received a definitive diagnosis. This highlights that most patients are lost to follow-up because of the two-step diagnostic process, which requires them to return to the health facility for confirmatory tests.\nContribution:\u00a0The study highlights the need to adopt HCV reflex testing as the standard in South Africa to meet the 2030 elimination targets.<\/jats:p>","DOI":"10.4102\/sajid.v41i1.778","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T12:36:45Z","timestamp":1774528605000},"update-policy":"https:\/\/doi.org\/10.4102\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Hepatitis C missed diagnostic opportunities: The role of reflex viral load testing in the era of direct acting antivirals, a descriptive South African study from 2017 to 2021"],"prefix":"10.4102","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0547-0012","authenticated-orcid":false,"given":"Hloniphile","family":"Mthiyane","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03rp50x72","id-type":"ROR","asserted-by":"publisher"}],"name":"University of the Witwatersrand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7128-0113","authenticated-orcid":false,"given":"Bonolo","family":"Mashishi","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00g0p6g84","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Pretoria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4924-1419","authenticated-orcid":false,"given":"Mamodiane A.","family":"Patjane","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03rp50x72","id-type":"ROR","asserted-by":"publisher"}],"name":"University of the Witwatersrand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7807-3811","authenticated-orcid":false,"given":"Ntwanano","family":"Honwana","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03rp50x72","id-type":"ROR","asserted-by":"publisher"}],"name":"University of the Witwatersrand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5300-0245","authenticated-orcid":false,"given":"Nishi","family":"Prabdial-Sing","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03rp50x72","id-type":"ROR","asserted-by":"publisher"}],"name":"University of the Witwatersrand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0330-4857","authenticated-orcid":false,"given":"Lucia","family":"Hans","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00znvbk37","id-type":"ROR","asserted-by":"publisher"}],"name":"National Health Laboratory Service"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8857-3844","authenticated-orcid":false,"given":"Nonhlanhla","family":"Mbenenge","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03rp50x72","id-type":"ROR","asserted-by":"publisher"}],"name":"University of the Witwatersrand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4506-4361","authenticated-orcid":false,"given":"Bhaveshan","family":"Reddy","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03rp50x72","id-type":"ROR","asserted-by":"publisher"}],"name":"University of the Witwatersrand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3643-3038","authenticated-orcid":false,"given":"Avania","family":"Bangalee","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01dak5k93","id-type":"ROR","asserted-by":"publisher"}],"name":"Lancet Laboratories"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0853-8011","authenticated-orcid":false,"given":"Florette K.","family":"Treurnicht","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03rp50x72","id-type":"ROR","asserted-by":"publisher"}],"name":"University of the Witwatersrand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2580","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"ref0","unstructured":"World Health Organization. Global hepatitis report 2024: Action for access in low- and middle-income countries [homepage on the Internet]. Geneva: World Health Organization; 2024 [cited 17 Nov 2025]. Available from: http:\/\/www.who.int\/health-topics\/hepatitis"},{"key":"ref1","unstructured":"World Health Organization. Hepatitis C [homepage on the Internet]. Geneva: World Health Organization; 2023 [cited 17 Nov 2025]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Fasano M, Ieva F, Ciarallo M, Caccianotti B, Santantonio TA. Acute hepatitis C: Current status and future perspectives. Viruses. 2024;16(11):1739. https:\/\/doi.org\/10.3390\/v16111739","DOI":"10.3390\/v16111739"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Lingala S, Ghany MG. Natural history of hepatitis C. Gastroenterol Clin North Am. 2015;44(4):717\u2013734. https:\/\/doi.org\/10.1016\/j.gtc.2015.07.003","DOI":"10.1016\/j.gtc.2015.07.003"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"O\u2019Brien TR, Yang HI, Groover S, Jeng WJ. Genetic factors that affect spontaneous clearance of hepatitis C or B virus, response to treatment, and disease progression. Gastroenterology. 2019;156(2):400\u2013417. https:\/\/doi.org\/10.1053\/j.gastro.2018.09.052","DOI":"10.1053\/j.gastro.2018.09.052"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Sonderup MW, Gogela N, Nordien R, et al. Direct-acting antiviral therapy for hepatitis C: The initial experience of the University of Cape Town\/Groote Schuur Hospital Liver Clinic, South Africa. S Afr Med J. 2020;110(2):112. https:\/\/doi.org\/10.7196\/SAMJ.2020.v110i2.14195","DOI":"10.7196\/SAMJ.2020.v110i2.14195"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Sonderup MW, Horak J, Smuts H, Saayman J, Boretti L, Black J. Expanding the epidemiological understanding of hepatitis C in South Africa: Perspectives from a patient cohort in a rural town. S Afr Med J. 2021;111(8):783. https:\/\/doi.org\/10.7196\/SAMJ.2021.v111i8.15477","DOI":"10.7196\/SAMJ.2021.v111i8.15477"},{"key":"ref7","unstructured":"National Department of Health, South Africa. National guidelines for the management of viral hepatitis [homepage on the Internet]. Pretoria: National Department of Health; 2019 [cited 17 Nov 2025]. Available from: https:\/\/sahivsoc.org\/Files\/SA%20NDOH_Viral%20Hepatitis%20guidelines%20final.pdf"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Bhattacharya D, Aronsohn A, Price J, et al. Hepatitis C guidance 2023 update: American Association for the study of liver diseases \u2013 Infectious Diseases Society of America recommendations for testing, managing, and treating hepatitis C virus infection. Clin Infect Dis. 2023:ciad319. https:\/\/doi.org\/10.1093\/cid\/ciad319","DOI":"10.1093\/cid\/ciad319"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Baumert TF, Berg T, Lim JK, Nelson DR. Status of direct-acting antiviral therapy for hepatitis C virus infection and remaining challenges. Gastroenterology. 2019;156(2):431\u2013445. https:\/\/doi.org\/10.1053\/j.gastro.2018.10.024","DOI":"10.1053\/j.gastro.2018.10.024"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Prabdial-Sing N, Gaelejwe L, Makhathini L, Thaver J, et al. The performance of hepatitis C virus antibody point-of-care tests on oral fluid or whole blood and dried blood spot testing for serology and viral load among individuals at higher risk for in South Africa. Health Sci Rep. 2021;4(1):e229. https:\/\/doi.org\/10.1002\/hsr2.229","DOI":"10.1002\/hsr2.229"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Trickey A, Fajardo E, Alemu D, Artenie AA, Easterbrook P. Impact of hepatitis C virus point-of-care RNA viral load testing compared with laboratory-based testing on uptake of RNA testing and treatment, and turnaround times: A systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2023;8(3):253\u2013270. https:\/\/doi.org\/10.1016\/S2468-1253(22)00346-6","DOI":"10.1016\/S2468-1253(22)00346-6"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Chang KV. Efficacy and safety of direct-acting antiviral regimens for hepatitis C virus infection: Protocol for a network meta-analysis. INPLASY. 2024;2024(11):0056. https:\/\/doi.org\/10.37766\/inplasy2024.11.0056","DOI":"10.37766\/inplasy2024.11.0056"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Kassa GM, Walker JG, Alamneh TS, et al. Prevalence, trends, and distribution of hepatitis C virus among the general population in sub-Saharan Africa: A systematic review and meta-analysis. Liver Int. 2024;44(12):3238\u20133249. https:\/\/doi.org\/10.1111\/liv.16170","DOI":"10.1111\/liv.16102"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Gogela NA, Sonderup MW, Rebe K, Chivese T, Spearman CW. Hepatitis C prevalence in HIV-infected heterosexual men and men who have sex with men. S Afr Med J. 2018;108(7):568. https:\/\/doi.org\/10.7196\/SAMJ.2018.v108i7.13041","DOI":"10.7196\/SAMJ.2018.v108i7.13041"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Saayman E, Hechter V, Kayuni N, Sonderup MW. A simplified point-of-service model for hepatitis C in people who inject drugs in South Africa. Harm Reduct J. 2023;20(1):7. https:\/\/doi.org\/10.1186\/s12954-023-00759-0","DOI":"10.1186\/s12954-023-00759-0"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Stroffolini T, Stroffolini G. Prevalence and modes of transmission of hepatitis C virus infection: A historical worldwide review. Viruses. 2024;16(7):1115. https:\/\/doi.org\/10.3390\/v16071115","DOI":"10.3390\/v16071115"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Van de Laar TJW, Van der Bij AK, Prins M, et al. Increase in HCV incidence among men who have sex with men in Amsterdam most likely caused by sexual transmission. J Infect Dis. 2007;196(2):230\u2013238. https:\/\/doi.org\/10.1086\/518796","DOI":"10.1086\/518796"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Jin F, Matthews GV, Grulich AE. Sexual transmission of hepatitis C virus among gay and bisexual men: A systematic review. Sex Health. 2017;14:28. https:\/\/doi.org\/10.1071\/SH16141","DOI":"10.1071\/SH16141"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Scheibe A, Young K, Versfeld A,. Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: Findings from a seven-city cross-sectional survey (2017). BMC Infect Dis. 2020;20(1):655. https:\/\/doi.org\/10.1186\/s12879-020-05359-y","DOI":"10.1186\/s12879-020-05359-y"},{"key":"ref20","unstructured":"World Health Organization. WHO publishes updated guidance on hepatitis C infection \u2013 With new recommendations on treatment of adolescents and children, simplified service delivery and diagnostics [homepage on the Internet]. World Health Organization. 2022 [cited 2025 Nov 17]. Available from: https:\/\/www.who.int\/news\/item\/24-06-2022-WHO-publishes-updated-guidance-on-hepatitis-C-infection"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Tamandjou Tchuem C, Cotton MF, Nel E, et al. Viral hepatitis B and C in HIV-exposed South African infants. BMC Pediatr. 2020;20:1. https:\/\/doi.org\/10.1186\/s12887-020-02479-x","DOI":"10.1186\/s12887-020-02479-x"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Nwaohiri A, Schillie S, Bulterys M, Kourtis AP. Hepatitis C virus infection in children: How do we prevent it and how do we treat it? Expert Rev Anti Infect Ther. 2018;16(9):689\u2013694. https:\/\/doi.org\/10.1080\/14787210.2018.1509707","DOI":"10.1080\/14787210.2018.1509707"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Ades AE, Gordon F, Scott K, et al. Spontaneous clearance of vertically acquired hepatitis C infection: Implications for testing and treatment. Clin Infect Dis. 2023;76(5):913\u2013921. https:\/\/doi.org\/10.1093\/cid\/ciac255","DOI":"10.1093\/cid\/ciac255"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Ng M, Carrieri PM, Awendila L, Soc\u00edas ME, Knight R, Ti L. Hepatitis C virus infection and hospital-related outcomes: A systematic review. Can J Gastroenterol Hepatol. 2024;2024:1\u201323. https:\/\/doi.org\/10.1155\/2024\/3325609","DOI":"10.1155\/2024\/3325609"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Hofmeister MG, Zhong Y, Moorman AC, Samuel CR, Teshale EH, Spradling PR. Temporal trends in hepatitis C \u2013 Related hospitalizations, United States, 2000\u20132019. Clin Infect Dis. 2023;77(12):1668\u20131675. https:\/\/doi.org\/10.1093\/cid\/ciad425","DOI":"10.1093\/cid\/ciad425"}],"container-title":["Southern African Journal of Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/sajid.co.za\/index.php\/sajid\/article\/view\/778\/2036","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T12:37:07Z","timestamp":1774528627000},"score":1,"resource":{"primary":{"URL":"https:\/\/sajid.co.za\/index.php\/sajid\/article\/view\/778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,1]]}},"URL":"https:\/\/doi.org\/10.4102\/sajid.v41i1.778","relation":{},"ISSN":["2312-0053","2313-1810"],"issn-type":[{"value":"2312-0053","type":"print"},{"value":"2313-1810","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"article-number":"a778"}}